Navigation Links
Lentigen Appoints Jim Meade as Vice President of Corporate Development
Date:6/16/2008

BALTIMORE, June 16 /PRNewswire/ -- Lentigen Corporation today announced the appointment of Jim Meade, Ph.D., CLP, as vice president of corporate development. In addition to contributing to the strategic direction of the company, Dr. Meade will be responsible for managing the development of Lentigen's partnerships, stakeholder relations, product and intellectual property portfolios, contract negotiations, and other key aspects of corporate development.

Tim Ravenscroft, CEO of Lentigen, commented, "Jim's extensive background in strategic development, opportunity evaluation, and negotiation will be an important asset to Lentigen as we continue to advance our business opportunities and collaborative relationships in biotherapeutics, vaccines and protein production."

Dr. Meade previously worked at Avalon Pharmaceuticals, where he served as vice president of business development. With more than 30 years' experience in the pharmaceutical and biotechnology industries, he has also held senior-level positions at Pharmacia, Bayer and Chiron. He holds a Ph.D. in molecular biology from the University of Texas, and is a Certified Licensing Professional and an active member of the Licensing Executives Society.

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine, and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of bench to clinical applications. Partnerships include The National Institutes of Health, The University of Pennsylvania, ThermoFisher Scientific and The U.S. Army. For further information, visit http://www.lentigen.com.

Contact:

Gregory Tiberend

gtiberend@rlcinc.com

Meghan Feeks

mfeeks@rlcinc.com

Richard Lewis Communications, Inc.

212-827-0020


'/>"/>
SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
2. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
3. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
4. Lentigen to Move Headquarters and Manufacturing to Gaithersburg
5. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
6. VIRxSYS and Lentigen Announce Litigation Settlement
7. NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
8. Applied Computational Technologies Appoints a New CEO
9. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, LLC, ... and medical device manufacturers and regulators, is proud to announce the worldwide release ... client designed to provide product vigilance departments with the flexibility and ease of ...
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
(Date:1/19/2017)... ... 2017 , ... FireflySci Inc. is a go-getter type of company that continues ... to two main factors. The first is the amazing customer service that the ... products all around the world. , 2016 was a tremendous sales year for FFS ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
Breaking Biology News(10 mins):